| Serial Number | 87604011 |
| Word Mark | NITYR |
| Filing Date | Monday, September 11, 2017 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 2, 2019 |
| Registration Number | 5716643 |
| Registration Date | Tuesday, April 2, 2019 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 4, 2018 |
| Goods and Services | (Based on 44(e)) Pharmaceutical agents for the treatment of disorders of the metabolism and digestive system, pharmaceutical agents for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; parts and fittings for all of the aforementioned goods.; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system, pharmaceutical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of tyrosinemia and hypertyrosinemia all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparations, namely, antioxidants; veterinary preparations namely, pain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system, supplements for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; (Based on Use in Commerce) food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system, biological preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for the treatment of disorders of the metabolism and digestive system, chemical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of disorders of the metabolism and digestive system, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system, drugs for the treatment of rare diseases, in particular for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes, enzyme preparations for the treatment of disorders of the metabolism and digestive system, enzyme preparations for the treatment of tyrosinemia and hypertyrosinemia, medical enzyme preparations in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems, medical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medicines for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches |
| Goods and Services | (Based on 44(e)) Advertising services; marketing services; business management; business administration services; providing office functions; advertising and marketing relating to medical and pharmaceutical goods and services; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; business information in the field of pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; business information in the field of pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements; providing business information; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; on-line wholesale store services featuring medical and pharmaceutical goods and services; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; promoting the goods and services of others via the internet in the medical and pharmaceutical industries; promoting the goods and services of others via the internet; retail pharmacy and drugstore services; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; retail store services featuring pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches |
| Goods and Services | (Based on 44(e)) Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dispensing of pharmaceuticals, medicines and supplements for the treatment of disorders of the metabolism and digestive system; dispensing of pharmaceuticals, medicines and supplements for the treatment of rare diseases; dispensing of pharmaceuticals, medicines and supplements for the treatment of tyrosinemia and hypertyrosinemia; dispensing of pharmaceuticals, medicines and supplements; dispensing of pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; genetic testing in relation to disorders of the metabolism and digestive system; genetic testing in relation to rare diseases; genetic testing in relation to tyrosinemia and hypertyrosinemia; genetic testing for medical purposes; providing healthcare and medical information in relation to disorders of the metabolism and digestive system; providing healthcare and medical information in relation to rare diseases; providing healthcare and medical information in relation to tyrosinemia and hypertyrosinemia; providing medical product information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing medical product information and advisory services in relation to the treatment of rare diseases; providing medical product information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; medical, pharmacological and pharmaceutical testing services for diagnostic and treatment purposes; medical, pharmacological and pharmaceutical testing services in relation to disorders of the metabolism and digestive system; medical, pharmacological and pharmaceutical testing services in relation to rare diseases; medical, pharmacological and pharmaceutical testing services in relation to tyrosinemia and hypertyrosinemia; providing pharmaceutical information and advisory services in relation to the treatment of disorders of the metabolism and digestive system; providing pharmaceutical information and advisory services in relation to the treatment of rare diseases; providing pharmaceutical information and advisory services in relation to the treatment of tyrosinemia and hypertyrosinemia; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of disorders of the metabolism and digestive system; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of rare diseases; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of tyrosinemia and hypertyrosinemia; providing news and information in the field of disorders of the metabolism and digestive system; providing news and information in the field of medicine in relation to tyrosinemia and hypertyrosinemia; providing news and information in the field of medicine; providing news and information in the field of rare diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 15, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, August 1, 2017 |
| First Use In Commerce Date | Tuesday, August 1, 2017 |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 15, 2017 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 15, 2017 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cycle Pharmaceuticals Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge CB21RR GB |
| Party Name | Cycle Pharmaceuticals Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge CB21RR GB |
| Party Name | Cycle Pharmaceuticals Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge CB21RR GB |
| Event Date | Event Description |
| Wednesday, April 3, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, April 3, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, April 3, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, April 2, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, March 15, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, March 15, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, March 15, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, October 28, 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Monday, May 20, 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 2, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, February 27, 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, February 26, 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, February 26, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 26, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 25, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 15, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 15, 2019 | NON-FINAL ACTION E-MAILED |
| Friday, February 15, 2019 | SU - NON-FINAL ACTION - WRITTEN |
| Thursday, February 14, 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, January 23, 2019 | USE AMENDMENT FILED |
| Thursday, February 14, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, January 23, 2019 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, January 17, 2019 | CORRECTED NOA E-MAILED |
| Tuesday, October 30, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 4, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 4, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 15, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, August 10, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, August 1, 2018 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, July 27, 2018 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Tuesday, July 24, 2018 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, July 13, 2018 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Thursday, July 12, 2018 | ELECTRONIC RECORD REVIEW COMPLETE |
| Friday, June 29, 2018 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, June 27, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 27, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, June 27, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 27, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 27, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, June 20, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 20, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 11, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, May 1, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 1, 2018 | NON-FINAL ACTION E-MAILED |
| Tuesday, May 1, 2018 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 11, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 11, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 5, 2018 | ASSIGNED TO LIE |
| Thursday, March 22, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, December 19, 2017 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, December 14, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 14, 2017 | NON-FINAL ACTION E-MAILED |
| Thursday, December 14, 2017 | NON-FINAL ACTION WRITTEN |
| Thursday, December 14, 2017 | ASSIGNED TO EXAMINER |
| Friday, September 15, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 14, 2017 | NEW APPLICATION ENTERED |